Press release article from our research archive:

Bedford Laboratories(TM) to Begin Shipping Ondansetron Injection USP.

BEDFORD, Ohio, Dec. 26 /PRNewswire/ -- Bedford Laboratories(TM), a division of Ben Venue Laboratories Inc., announced that it will begin marketing Ondansetron Injection USP as of December 26, 2006. This product is AP rated and is equivalent to Zofran(R) by GlaxoSmithKline. Ondansetron Injection USP is indicated for prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, including high-dose cisplatin. It is also indicated for prevention of postoperative nausea and/or vomiting.

"As part of our objective to offer an extensive selection of specialty products to meet the changing needs of healthcare professionals, we are ...

Related newspaper, magazine, and journal articles:

See all results. Or, try our Advanced Search.

Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 60 million articles! Access over 3,500 publications with a FREE trial!